ADVI Health’s Lindsay Bealor Greenleaf Featured in Pharmaceutical Executive
Lindsay Bealor Greenleaf, JD, MBA
April 14, 2026
On March 31, Lindsay Bealor Greenleaf, ADVI’s senior vice president and head of market access policy strategy (MAPS), was featured in Pharmaceutical Executive‘s article, “How Will MFN’s Effects on Medicare Impact Innovation?”
In the article, Lindsay shares insight on the current state of Most Favored Nation (MFN), it’s role within TrumpRx, and how these changes will impact Medicare patients.
Read more of Lindsay’s insights in Pharmaceutical Executive.
Lindsay Bealor Greenleaf, JD, MBA
Senior Vice President, Market Access and Policy Strategy
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.